Why the study?
Does intravenous amiodarone therapy cause early malignant torsades de pointes in susceptible patients?
Population
A patient with heart failure, hypokalemia, and digoxin use (n=1)
Design
Case_report
Follow-up
within the first 24 hours
Authors
Loading...
May warrant close monitoring for early torsades with IV amiodarone; leaves open rechallenge safety after factor correction.
Does intravenous amiodarone therapy cause early malignant torsades de pointes in susceptible patients?
Intravenous amiodarone can cause early malignant torsades de pointes, and readministration remains hazardous even after correcting predisposing factors.
Tomcsányi et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: